SCHEMBL7209158

SCHEMBL7209158

CSc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccnc(Oc4ccccc4)c3)[nH]2)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 17/20 0.62
MAPK13 O15264 11/20 0.62
MAPK12 P53778 11/20 0.62
MAPK11 Q15759 11/20 0.62
ALOX5 P09917 6/20 0.62
GCGR P47871 6/20 0.62
PRKD3 O94806 2/20 0.62
MAP4K4 O95819 2/20 0.62
FRK P42685 2/20 0.62
MAPK9 P45984 2/20 0.62
CSNK1A1 P48729 2/20 0.62
CSNK1D P48730 2/20 0.62
GSK3B P49841 2/20 0.62
PRKD2 Q9BZL6 2/20 0.62
CLK4 Q9HAZ1 2/20 0.62
LCK P06239 1/20 0.62
RET P07949 1/20 0.62
PRKACA P17612 1/20 0.62
RPS6KB1 P23443 1/20 0.62
MATK P42679 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7206018 0.84 ALOX5 (0.64) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL13712660 0.84 MAPK14 (0.83) MAPK14MAPK13MAPK12MAPK11EGFR
SCHEMBL4584929 0.82 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL7209162 0.81 MAPK14 (0.55) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL1388020 0.77 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL22170123 0.77 MAPK11 (1.00) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL2650007 0.75 MAPK14 (0.81) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL4460400 0.75 MAPK14 (1.00) MAPK14MAPK13MAPK12MAPK11EGFR
SCHEMBL1131081 0.74 MAPK13 (0.67) MAPK14MAPK13MAPK12MAPK11ALOX5
SCHEMBL4585131 0.74 MAPK14 (0.62) MAPK14MAPK13MAPK12MAPK11MAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP claimed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP claimed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO claimed
US-6610695-B1 Prophylaxis or treatment of CSBP/RK/p38 kinase mediated disease SMITHKLINE BEECHAM CORPORATION 2003-08-26 US disclosed
EP-0994870-A4 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM (US) 2002-10-23 EP disclosed
EP-0994870-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS Smithkline Beecham (US) 2000-04-26 EP disclosed
WO-1998057966-A1 NOVEL ARYLOXY SUBSTITUTED PYRIMIDINE IMIDAZOLE COMPOUNDS SMITHKLINE BEECHAM CORPORATION (US) 1998-12-23 WO disclosed